Cargando…
Targeting DNA-PKcs and telomerase in brain tumour cells
BACKGROUND: Patients suffering from brain tumours such as glioblastoma and medulloblastoma have poor prognosis with a median survival of less than a year. Identifying alternative molecular targets would enable us to develop different therapeutic strategies for better management of these tumours. MET...
Autores principales: | Gurung, Resham Lal, Lim, Hui Kheng, Venkatesan, Shriram, Lee, Phoebe Su Wen, Hande, M Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213508/ https://www.ncbi.nlm.nih.gov/pubmed/25307264 http://dx.doi.org/10.1186/1476-4598-13-232 |
Ejemplares similares
-
Inhibition of poly (ADP-Ribose) polymerase-1 in telomerase deficient mouse embryonic fibroblasts increases arsenite-induced genome instability
por: Gurung, Resham L, et al.
Publicado: (2010) -
DNA-PKcs: A Targetable Protumorigenic Protein Kinase
por: Dylgjeri, Emanuela, et al.
Publicado: (2022) -
Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs
por: Espejel, Silvia, et al.
Publicado: (2004) -
KU-0060648 inhibits hepatocellular carcinoma cells through DNA-PKcs-dependent and DNA-PKcs-independent mechanisms
por: Chen, Min-Bin, et al.
Publicado: (2016) -
Telomerase activity in 144 brain tumours.
por: Sano, T., et al.
Publicado: (1998)